DNA polymerase activity of hepatitis B virus particles: differential inhibition by l-enantiomers of nucleotide analogs
✍ Scribed by Michelle G. Davis; Jeanne E. Wilson; Nanine A. VanDraanen; Wayne H. Miller; George A. Freeman; Susan M. Daluge; Frank L. Boyd; Ann E. Aulabaugh; George R. Painter; Lawrence R. Boone
- Book ID
- 113259426
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 937 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0166-3542
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Replication of hepadnaviruses involves a viral DNA polymerase containing both a DNA-dependent and an RNA dependent activity. This polymerase is a potential target for chemotherapy against hepatitis B. We have used human hepatitis B virus DNA-dependent DNA polymerase from human serum and duck hepatit
## Abstract The 3′‐fluoromodified nucleotide analogs 3′‐fluorothymidine triphosphate (FdTTP), 2′,3′‐dideoxy‐3′‐fluoro‐5‐chlorouridine triphosphate (F‐5CldUTP), 2′,3′‐dideoxy‐3′‐fluoro‐5‐ethyluridine triphosphate (F‐5EtdUTP), 2′,3′‐dideoxy‐3′‐fluorouridine triphosphate (FdUTP), and 2′,3′‐dideoxy‐3′‐
The deoxyguanosine analog penciclovir (PCV; 9-[4-hydroxy-3-hydroxymethyl-but-1-yl]guanine), has shown potent antiviral activity against herpes viruses and hepadnaviruses. Efficacy against chronic hepatitis B virus (HBV) infection has been demonstrated in an animal model and in recent clinical trials